blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2768945

EP2768945 - MEDIA FOR STEM CELL PROLIFERATION AND INDUCTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.11.2022
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  03.12.2021
FormerGrant of patent is intended
Status updated on  20.05.2021
FormerExamination is in progress
Status updated on  21.11.2016
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Minerva Biotechnologies Corporation
40 Bear Hill Rd.
Waltham, MA 02451 / US
[2022/01]
Former [2014/35]For all designated states
Minerva Biotechnologies Corporation
40 Bear Hill Rd.
Waltham, MA 02451 / US
Inventor(s)01 / BAMDAD, Cynthia
40 Bear Hill Road
Waltham, MA 02451 / US
02 / SMAGGHE, Benoit
40 Bear Hill Road
Waltham, MA 02451 / US
 [2014/35]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/01]
Former [2014/35]Cowley, Catherine Mary, et al
Venner Shipley LLP
200 Aldersgate
London EC1A 4HD / GB
Application number, filing date12841648.417.10.2012
[2022/01]
WO2012US60684
Priority number, dateUS201161548199P17.10.2011         Original published format: US 201161548199 P
US201261618578P30.03.2012         Original published format: US 201261618578 P
US201261622422P10.04.2012         Original published format: US 201261622422 P
WO2012US3697508.05.2012         Original published format: PCT/US2012/036975
US201261671588P13.07.2012         Original published format: US 201261671588 P
US201261671558P13.07.2012         Original published format: US 201261671558 P
US201261673617P19.07.2012         Original published format: US 201261673617 P
US201261675264P24.07.2012         Original published format: US 201261675264 P
US201261675292P24.07.2012         Original published format: US 201261675292 P
US201261677442P30.07.2012         Original published format: US 201261677442 P
US201261679021P02.08.2012         Original published format: US 201261679021 P
US201261683155P14.08.2012         Original published format: US 201261683155 P
US201261684654P17.08.2012         Original published format: US 201261684654 P
US201261693712P27.08.2012         Original published format: US 201261693712 P
[2014/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2013059373
Date:25.04.2013
Language:EN
[2013/17]
Type: A2 Application without search report 
No.:EP2768945
Date:27.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 25.04.2013 takes the place of the publication of the European patent application.
[2014/35]
Type: B1 Patent specification 
No.:EP2768945
Date:05.01.2022
Language:EN
[2022/01]
Search report(s)International search report - published on:US20.06.2013
(Supplementary) European search report - dispatched on:EP29.06.2015
ClassificationIPC:C12N5/00, C12N5/02, C12N5/0735, C12N5/074
[2015/31]
CPC:
C12N5/0606 (EP,US); C12N5/0607 (US); C12N5/0037 (EP,US);
C12N5/0056 (EP,US); C12N2500/90 (US); C12N2501/00 (US);
C12N2501/10 (US); C12N2501/115 (US); C12N2501/15 (US);
C12N2501/727 (EP,US); C12N2501/90 (US) (-)
Former IPC [2014/35]C12N5/00, C12N5/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/35]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MEDIEN ZUR STAMMZELLENPROLIFERATION UND -INDUZIERUNG[2014/35]
English:MEDIA FOR STEM CELL PROLIFERATION AND INDUCTION[2014/35]
French:MILIEU POUR LA PROLIFÉRATION ET L'INDUCTION DE CELLULES SOUCHES[2014/35]
Entry into regional phase17.04.2014National basic fee paid 
17.04.2014Search fee paid 
17.04.2014Designation fee(s) paid 
17.04.2014Examination fee paid 
Examination procedure17.04.2014Examination requested  [2014/35]
20.04.2016Amendment by applicant (claims and/or description)
13.07.2016Despatch of a communication from the examining division (Time limit: M06)
03.05.2017Reply to a communication from the examining division
15.11.2017Despatch of a communication from the examining division (Time limit: M06)
03.09.2018Reply to a communication from the examining division
01.07.2019Despatch of a communication from the examining division (Time limit: M06)
04.02.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
14.04.2020Reply to a communication from the examining division
21.05.2021Communication of intention to grant the patent
27.09.2021Fee for grant paid
27.09.2021Fee for publishing/printing paid
27.09.2021Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.07.2016
Opposition(s)06.10.2022No opposition filed within time limit [2022/50]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
14.04.2020Request for further processing filed
14.04.2020Full payment received (date of receipt of payment)
Request granted
23.04.2020Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
30.08.2018Request for further processing filed
30.08.2018Full payment received (date of receipt of payment)
Request granted
07.09.2018Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
03.05.2017Request for further processing filed
03.05.2017Full payment received (date of receipt of payment)
Request granted
15.05.2017Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
20.04.2016Request for further processing filed
20.04.2016Full payment received (date of receipt of payment)
Request granted
29.04.2016Decision despatched
Fees paidRenewal fee
30.04.2015Renewal fee patent year 03
30.10.2015Renewal fee patent year 04
18.10.2016Renewal fee patent year 05
26.10.2017Renewal fee patent year 06
18.10.2018Renewal fee patent year 07
28.10.2019Renewal fee patent year 08
09.10.2020Renewal fee patent year 09
29.11.2021Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.10.201403   M06   Fee paid on   30.04.2015
31.10.202110   M06   Fee paid on   29.11.2021
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.10.2012
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
MT05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
TR05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
[2024/41]
Former [2024/29]HU17.10.2012
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
TR05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2024/27]HU17.10.2012
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2024/21]HU17.10.2012
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2024/18]HU17.10.2012
AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/35]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/25]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/10]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/01]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/49]AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/48]AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/47]AT05.01.2022
DK05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/46]AT05.01.2022
DK05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/42]AT05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/39]AT05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
PT05.05.2022
Former [2022/36]AT05.01.2022
ES05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
PT05.05.2022
Former [2022/35]ES05.01.2022
HR05.01.2022
LT05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
PT05.05.2022
Former [2022/34]ES05.01.2022
LT05.01.2022
NO05.04.2022
PT05.05.2022
Former [2022/33]LT05.01.2022
NO05.04.2022
Documents cited:Search[XY]WO2008070171  (MINERVA BIOTECHNOLOGIES CORP [US], et al) [X] 15-19 * claims 1-30 * [Y] 1-14,20,21;
 [X]WO2010042891  (MINERVA BIOTECHNOLOGIES CORP [US], et al) [X] 1-21 * paragraphs [0010] , [0037] , [0038]; examples 1,11,12 *;
 [XY]US2010316688  (BAMDAD CYNTHIA C [US]) [X] 14 * claims 1-10 *[Y] 1-13,15-21;
 [Y]  - HIKITA SHERRY T ET AL, "MUC1* mediates the growth of human pluripotent stem cells", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, (20081003), vol. 3, no. 10, doi:10.1371/JOURNAL.PONE.0003312, ISSN 1932-6203, page E3312, XP002560322 [Y] 1-21 * page 10, paragraph last; figures 1,3,4 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0003312
International search[X]US2010093092  (BAMDAD CYNTHIA C [US], et al);
 [A]US2010278788  (BADOER CINDY [BE], et al);
 [A]US2010316688  (BAMDAD CYNTHIA C [US]);
 [Y]US2011014164  (HUANGFU DANWEI [US], et al);
 [Y]  - MEHUS ET AL., "NDK7_HUMAN", UNIPROT, (20110531), Database accession no. NDK7_HUMAN, XP003032873
 [Y]  - MEHUS ET AL., "NME6: a new member of the NME23/nucleoside diphosphate kinase gene family located on human chromosome 3p21.3.", HUMAN GENETICS., (199906), vol. 104, no. 6, pages 454 - 459, XP055148861

DOI:   http://dx.doi.org/10.1007/s004390050987
 [Y]  - SUMER ET AL., "The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.", THERIOGENOLOGY., (20100901), vol. 74, no. 4, pages 525 - 533, XP027205544
 [Y]  - FLETCHER ET AL., "Variations in Humanized and Defined Culture Conditions Supporting Derivation of New Human Embryonic Stem Cell Lines.", CLONING AND STEM CELLS., (2006), vol. 8, no. 4, pages 319 - 334, XP009165864

DOI:   http://dx.doi.org/10.1089/clo.2006.8.319
Examination   - A. J. Lilly ET AL, "Nm23-H1 Indirectly Promotes the Survival of Acute Myeloid Leukemia Blast Cells by Binding to More Mature Components of the Leukemic Clone", CANCER RESEARCH, US, (20110201), vol. 71, no. 3, doi:10.1158/0008-5472.CAN-10-1704, ISSN 0008-5472, pages 1177 - 1186, XP055236075

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-10-1704
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.